1. Home
  2. ICCC vs TPCS Comparison

ICCC vs TPCS Comparison

Compare ICCC & TPCS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ICCC
  • TPCS
  • Stock Information
  • Founded
  • ICCC 1982
  • TPCS 1956
  • Country
  • ICCC United States
  • TPCS United States
  • Employees
  • ICCC N/A
  • TPCS N/A
  • Industry
  • ICCC Biotechnology: Pharmaceutical Preparations
  • TPCS Metal Fabrications
  • Sector
  • ICCC Health Care
  • TPCS Industrials
  • Exchange
  • ICCC Nasdaq
  • TPCS Nasdaq
  • Market Cap
  • ICCC 57.4M
  • TPCS 51.4M
  • IPO Year
  • ICCC 1987
  • TPCS N/A
  • Fundamental
  • Price
  • ICCC $6.61
  • TPCS $5.47
  • Analyst Decision
  • ICCC
  • TPCS
  • Analyst Count
  • ICCC 0
  • TPCS 0
  • Target Price
  • ICCC N/A
  • TPCS N/A
  • AVG Volume (30 Days)
  • ICCC 17.1K
  • TPCS 30.5K
  • Earning Date
  • ICCC 11-12-2025
  • TPCS 08-21-2025
  • Dividend Yield
  • ICCC N/A
  • TPCS N/A
  • EPS Growth
  • ICCC N/A
  • TPCS N/A
  • EPS
  • ICCC 0.20
  • TPCS N/A
  • Revenue
  • ICCC $28,274,756.00
  • TPCS $33,424,000.00
  • Revenue This Year
  • ICCC N/A
  • TPCS N/A
  • Revenue Next Year
  • ICCC N/A
  • TPCS N/A
  • P/E Ratio
  • ICCC $32.15
  • TPCS N/A
  • Revenue Growth
  • ICCC 21.75
  • TPCS 3.78
  • 52 Week Low
  • ICCC $3.38
  • TPCS $2.05
  • 52 Week High
  • ICCC $7.60
  • TPCS $6.25
  • Technical
  • Relative Strength Index (RSI)
  • ICCC 58.43
  • TPCS 55.73
  • Support Level
  • ICCC $6.30
  • TPCS $5.18
  • Resistance Level
  • ICCC $6.99
  • TPCS $5.67
  • Average True Range (ATR)
  • ICCC 0.30
  • TPCS 0.20
  • MACD
  • ICCC 0.06
  • TPCS -0.01
  • Stochastic Oscillator
  • ICCC 69.06
  • TPCS 68.86

About ICCC ImmuCell Corporation

ImmuCell Corp is engaged in the healthcare sector. The company operates in the development, acquisition, manufacture, and sale of products that improve the health and productivity of cows for the dairy and beef industries. The company operates in two business segment. The Scours segment is dedicated to manufacturing and selling First Defense, a product used to prevent scours in newborn calves, which is regulated by the United States Department of Agriculture (USDA). The Mastitis segment is focused on developing and commercializing Re-Tain, a product to treat subclinical mastitis in lactating dairy cows, which is regulated by the United States Food and Drug Administration (FDA). The company generates the majority of its revenue from the Scours segment.

About TPCS TechPrecision Corporation Common stock

Techprecision Corp manufactures metal fabricated and machined precision components and systems. It offers a full range of services required to transform raw materials into precision finished products. The company's products are used in markets including defense, aerospace, nuclear, medical, and precision industries. All of its operations and customers are located in the United States. The company have two wholly owned subsidiaries that are each reportable segments: Ranor and Stadco. Each reportable segment focuses on the manufacture and assembly of specific components. It derives maximum revenue from Ranor segment.

Share on Social Networks: